Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of Gastrointestinal Oncology|January 4, 2019
Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancerBrandon R Mancini, Stacey Stein, Shane Lloyd, et al.Pancreas|July 14, 2020
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic CancerMichael Cecchini, Joseph A Miccio, Jay Pahade, et al.American Journal of Clinical Oncology|August 22, 2014
Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal AdenocarcinomaJia Li, Xiaopan Yao, Jeremy S Kortmansky, et al.European Radiology|July 20, 2024
Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-makingRabea Sobirey, Nickolai Matuschewski, Moritz Gross, et al.Journal of Gastrointestinal Oncology|July 11, 2024
A single arm phase 2 clinical trial of YIV-906 with neoadjuvant concurrent chemo-radiation therapy in patients with locally advanced rectal cancerNipun Verma, Kimberly L Johung, Jeremy Kortmansky, et al.Journal of Gastrointestinal Oncology|July 12, 2023
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancerGabrielle W Peters, Wesley Talcott, Nicholas V Peters, et al.The Lancet. Oncology|June 6, 2020
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b studyMichael S Lee, Baek-Yeol Ryoo, Chih-Hung Hsu, et al.Investigational New Drugs|October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.Investigational New Drugs|September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.American Journal of Clinical Oncology|November 1, 2022
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas CancerMeriem Mokhtech, Joseph A Miccio, Kimberly Johung, et al.Pageof 4